Table 6 TEAEs occurring in 2 or more patients during the main study, n (%) (Safety Population)
Symptom | Ovaleap® (n = 153) | Gonal-f® (n = 146) | Total (N = 299) |
|---|---|---|---|
OHSS | 7 (4.6) | 4 (2.7) | 11 (3.7)* |
Abdominal pain | 5 (3.3) | 1 (0.7) | 6 (2.0) |
Abortion missed | 0 | 3 (2.1) | 3 (1.0) |
Ectopic pregnancy | 2 (1.3) | 1 (0.7) | 3 (1.0)** |
Nasopharyngitis | 1 (0.7) | 2 (1.4) | 3 (1.0) |
Nausea | 2 (1.3) | 1 (0.7) | 3 (1.0) |
Antepartum hemorrhage | 1 (0.7) | 1 (0.7) | 2 (0.7) |
Headache | 2 (1.3) | 0 | 2 (0.7) |